K851521

Substantially Equivalent

LD-1(IMMUNO) SEPARATION SET

Applicant: Seragen Diagnostics, Inc.
Product code: CEX
Advisory panel: Clinical Chemistry
Date received: 1985-04-15
Decision date: 1985-05-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.